Adzenys XR-ODT
Amphetamine
- Strength
- 6.3 mg/1
- Form
- Tablet, Orally Disintegrating
- Class
- Central Nervous System Stimulant
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
amphetamine
Listed by NextWave Pharmaceuticals, Inc
| Dosage form | Tablet, Extended Release |
|---|---|
| Route | Oral |
| Drug class | Central Nervous System Stimulant |
| Approval route | NDA — original brand approval |
| NDC code | 24478-106 |
| FDA application | NDA210526 |
| RxNorm concept | 1720586 |
| Package sizes listed | 1 |
| Marketed since | November 2021 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Amphetamine
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
Amphetamine
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
Amphetamine
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
Amphetamine
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
Amphetamine
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
Amphetamine
Neos Therapeutics Brands, LLC
Not stocked by us — reference only
Teva Pharmaceuticals, Inc.
Not stocked by us — reference only
Teva Pharmaceuticals, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.